Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach Publication Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach Danielle Pillsbury2017年9月15日
Drug Asset Evaluation: Increasing “Probability of Success” of a Deal White Paper Drug Asset Evaluation: Increasing “Probability of Success” of a Deal Certara’s due diligence/asset evaluation teams are comprised of drug development and commercialization experts who advise…Danielle Pillsbury2017年8月24日
Investigational Drug Gap Analysis Brochure Investigational Drug Gap Analysis As the process of drug development has increased in cost and complexity, Certara has developed…Danielle Pillsbury2017年8月14日
Clinical Pharmacology—The Quarterback of Drug Development Article Clinical Pharmacology—The Quarterback of Drug Development Clinical pharmacology accounts for about 50% of a drug label. Its scope ranges from facilitating…Certara2017年8月14日
Mind the Gap: Best Practices in Clinical Pharmacology Gap Analysis Blog Mind the Gap: 臨床薬理学のギャップ分析におけるベストプラクティス Do you get anxious about taking tests? Many people do because they want to show…Certara2017年5月25日
A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor Publication A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor Danielle Pillsbury2017年1月10日
Lessons Learned: Dose Selection of Small Molecule-targeted Oncology Drugs Publication 得られた教訓 : Dose Selection of Small Molecule-targeted Oncology Drugs Danielle Pillsbury2016年6月1日
Trial Designs—Non-inferiority vs. Superiority vs. Equivalence BlogKnowledge Base Trial Designs—Non-inferiority vs. Superiority vs. Equivalence The primary purpose of a clinical trial is to address a scientific hypothesis. To address…Certara2011年1月1日